These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 20513829)

  • 41. Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
    Manchikanti L; Kaye AM; Knezevic NN; McAnally H; Slavin K; Trescot AM; Blank S; Pampati V; Abdi S; Grider JS; Kaye AD; Manchikanti KN; Cordner H; Gharibo CG; Harned ME; Albers SL; Atluri S; Aydin SM; Bakshi S; Barkin RL; Benyamin RM; Boswell MV; Buenaventura RM; Calodney AK; Cedeno DL; Datta S; Deer TR; Fellows B; Galan V; Grami V; Hansen H; Helm Ii S; Justiz R; Koyyalagunta D; Malla Y; Navani A; Nouri KH; Pasupuleti R; Sehgal N; Silverman SM; Simopoulos TT; Singh V; Solanki DR; Staats PS; Vallejo R; Wargo BW; Watanabe A; Hirsch JA
    Pain Physician; 2017 Feb; 20(2S):S3-S92. PubMed ID: 28226332
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preventing and managing aberrant drug-related behavior in primary care: systematic review of outcomes evidence.
    Argoff CE; Kahan M; Sellers EM
    J Opioid Manag; 2014; 10(2):119-34. PubMed ID: 24715667
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Multicomponent Intervention to Improve Primary Care Provider Adherence to Chronic Opioid Therapy Guidelines and Reduce Opioid Misuse: A Cluster Randomized Controlled Trial Protocol.
    Lasser KE; Shanahan C; Parker V; Beers D; Xuan Z; Heymann O; Lange A; Liebschutz JM
    J Subst Abuse Treat; 2016 Jan; 60():101-9. PubMed ID: 26256769
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A systematic review of assessment approaches to predict opioid misuse in people with cancer.
    Keall R; Keall P; Kiani C; Luckett T; McNeill R; Lovell M
    Support Care Cancer; 2022 Jul; 30(7):5645-5658. PubMed ID: 35166898
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Monitoring opioid adherence in chronic pain patients: assessment of risk of substance misuse.
    Solanki DR; Koyyalagunta D; Shah RV; Silverman SM; Manchikanti L
    Pain Physician; 2011; 14(2):E119-31. PubMed ID: 21412377
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhancing system-wide implementation of opioid prescribing guidelines in primary care: protocol for a stepped-wedge quality improvement project.
    Zgierska AE; Vidaver RM; Smith P; Ales MW; Nisbet K; Boss D; Tuan WJ; Hahn DL
    BMC Health Serv Res; 2018 Jun; 18(1):415. PubMed ID: 29871625
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of the Opioid Compliance Checklist to Monitor Chronic Pain Patients Receiving Opioid Therapy in Primary Care.
    Jamison RN; Martel MO; Huang CC; Jurcik D; Edwards RR
    J Pain; 2016 Apr; 17(4):414-23. PubMed ID: 26705974
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Addressing the intersecting problems of opioid misuse and chronic pain treatment.
    Denisco RA; Chandler RK; Compton WM
    Exp Clin Psychopharmacol; 2008 Oct; 16(5):417-28. PubMed ID: 18837638
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Substance misuse treatment for high-risk chronic pain patients on opioid therapy: a randomized trial.
    Jamison RN; Ross EL; Michna E; Chen LQ; Holcomb C; Wasan AD
    Pain; 2010 Sep; 150(3):390-400. PubMed ID: 20334973
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risks, management, and monitoring of combination opioid, benzodiazepines, and/or alcohol use.
    Gudin JA; Mogali S; Jones JD; Comer SD
    Postgrad Med; 2013 Jul; 125(4):115-30. PubMed ID: 23933900
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines.
    Trescot AM; Helm S; Hansen H; Benyamin R; Glaser SE; Adlaka R; Patel S; Manchikanti L
    Pain Physician; 2008 Mar; 11(2 Suppl):S5-S62. PubMed ID: 18443640
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interpretation of urine drug testing in pain patients.
    Pesce A; West C; Egan City K; Strickland J
    Pain Med; 2012 Jul; 13(7):868-85. PubMed ID: 22494459
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.
    Chou R; Fanciullo GJ; Fine PG; Adler JA; Ballantyne JC; Davies P; Donovan MI; Fishbain DA; Foley KM; Fudin J; Gilson AM; Kelter A; Mauskop A; O'Connor PG; Passik SD; Pasternak GW; Portenoy RK; Rich BA; Roberts RG; Todd KH; Miaskowski C;
    J Pain; 2009 Feb; 10(2):113-30. PubMed ID: 19187889
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Opioids in chronic noncancer pain.
    Manchikanti L; Benyamin R; Datta S; Vallejo R; Smith H
    Expert Rev Neurother; 2010 May; 10(5):775-89. PubMed ID: 20420496
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Opioids for chronic noncancer pain. Tailoring therapy to fit the patient and the pain.
    Antoin H; Beasley RD
    Postgrad Med; 2004 Sep; 116(3):37-40, 43-4. PubMed ID: 15460088
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of opioid medications for chronic noncancer pain syndromes in primary care.
    Reid MC; Engles-Horton LL; Weber MB; Kerns RD; Rogers EL; O'Connor PG
    J Gen Intern Med; 2002 Mar; 17(3):173-9. PubMed ID: 11929502
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Opioid therapy in patients with chronic noncancer pain: diagnostic and clinical challenges.
    Cheatle MD; O'Brien CP
    Adv Psychosom Med; 2011; 30():61-91. PubMed ID: 21508626
    [TBL] [Abstract][Full Text] [Related]  

  • 58. What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review.
    Fishbain DA; Cole B; Lewis J; Rosomoff HL; Rosomoff RS
    Pain Med; 2008; 9(4):444-59. PubMed ID: 18489635
    [TBL] [Abstract][Full Text] [Related]  

  • 59. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part I--evidence assessment.
    Manchikanti L; Abdi S; Atluri S; Balog CC; Benyamin RM; Boswell MV; Brown KR; Bruel BM; Bryce DA; Burks PA; Burton AW; Calodney AK; Caraway DL; Cash KA; Christo PJ; Damron KS; Datta S; Deer TR; Diwan S; Eriator I; Falco FJ; Fellows B; Geffert S; Gharibo CG; Glaser SE; Grider JS; Hameed H; Hameed M; Hansen H; Harned ME; Hayek SM; Helm S; Hirsch JA; Janata JW; Kaye AD; Kaye AM; Kloth DS; Koyyalagunta D; Lee M; Malla Y; Manchikanti KN; McManus CD; Pampati V; Parr AT; Pasupuleti R; Patel VB; Sehgal N; Silverman SM; Singh V; Smith HS; Snook LT; Solanki DR; Tracy DH; Vallejo R; Wargo BW;
    Pain Physician; 2012 Jul; 15(3 Suppl):S1-65. PubMed ID: 22786448
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.